You are here

AB Science

Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease

BioSpace

Mon, 07/24/23 - 09:57 am

neurodegenerative disease

Alzheimer's disease

Axsome Therapeutics

BrainStorm Cell Therapeutics

Seelos Therapeutics

Parkinson's Disease

Mitsubishi Tanabe Pharma

Huntington's disease

Prilenia Therapeutics

Biogen leads the amyotrophic lateral sclerosis hopefuls

EP Vantage

Thu, 09/16/21 - 10:41 am

Ionis Pharmaceuticals

AB Science Announces Significant Survival Data for Masitinib in ALS

BioSpace

Tue, 07/20/21 - 11:02 am

clinical trials

Clinical studies for AB Science's all-purpose anti-inflammatory drug grind to a halt as company flags potential risk of heart disease

Endpoints

Tue, 06/1/21 - 11:00 am

Alzheimer's disease

A Drug for Dogs Does Not a Biotech Make Is AB Science Lesson

Bloomberg

Fri, 06/12/15 - 09:35 am

AB Soars 46% as Cancer Drug Beats Pfizer’s Sutent: Paris Mover

Bloomberg

Thu, 02/2/12 - 09:15 am

gastrointestinal cancer